Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
Chapter 5: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
Chapter 6: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
Chapter 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
Chapter 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Roche Diagnostics
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Sysmex Corporation
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Siemens Healthcare
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Arkray Inc.
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Otsuka Pharmaceutical Co.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. FUJIFILM Holdings Corp.
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. ETHICON, Inc.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Novo Nordisk A/S
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. OLYMPUS CORPORATION
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ABBOTT LABORATORIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 21. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ABBOTT LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ROCHE DIAGNOSTICS: NET SALES, 2020-2022*?($MILLION)
FIGURE 24. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ROCHE DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. SYSMEX CORPORATION: NET SALES, 2020-2022*?($MILLION)
FIGURE 27. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. SYSMEX CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. SIEMENS HEALTHCARE: NET SALES, 2020-2022*?($MILLION)
FIGURE 30. SIEMENS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. SIEMENS HEALTHCARE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. ARKRAY INC.: NET SALES, 2020-2022*?($MILLION)
FIGURE 33. ARKRAY INC.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. ARKRAY INC.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. OTSUKA PHARMACEUTICAL CO.: NET SALES, 2020-2022*?($MILLION)
FIGURE 36. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. FUJIFILM HOLDINGS CORP.: NET SALES, 2020-2022*?($MILLION)
FIGURE 39. FUJIFILM HOLDINGS CORP.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. FUJIFILM HOLDINGS CORP.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. ETHICON, INC.: NET SALES, 2020-2022*?($MILLION)
FIGURE 42. ETHICON, INC.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. ETHICON, INC.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. NOVO NORDISK A/S: NET SALES, 2020-2022*?($MILLION)
FIGURE 45. NOVO NORDISK A/S: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. NOVO NORDISK A/S: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. OLYMPUS CORPORATION: NET SALES, 2020-2022*?($MILLION)
FIGURE 48. OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. OLYMPUS CORPORATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 05. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 06. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 07. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 08. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 09. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 10. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 11. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 12. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 13. ROCHE DIAGNOSTICS: KEY STRATERGIES
TABLE 14. SYSMEX CORPORATION: KEY EXECUTIVES
TABLE 15. SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 16. SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 17. SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 18. SYSMEX CORPORATION: KEY STRATERGIES
TABLE 19. SIEMENS HEALTHCARE: KEY EXECUTIVES
TABLE 20. SIEMENS HEALTHCARE: COMPANY SNAPSHOT
TABLE 21. SIEMENS HEALTHCARE: OPERATING SEGMENTS
TABLE 22. SIEMENS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 23. SIEMENS HEALTHCARE: KEY STRATERGIES
TABLE 24. ARKRAY INC.: KEY EXECUTIVES
TABLE 25. ARKRAY INC.: COMPANY SNAPSHOT
TABLE 26. ARKRAY INC.: OPERATING SEGMENTS
TABLE 27. ARKRAY INC.: PRODUCT PORTFOLIO
TABLE 28. ARKRAY INC.: KEY STRATERGIES
TABLE 29. OTSUKA PHARMACEUTICAL CO.: KEY EXECUTIVES
TABLE 30. OTSUKA PHARMACEUTICAL CO.: COMPANY SNAPSHOT
TABLE 31. OTSUKA PHARMACEUTICAL CO.: OPERATING SEGMENTS
TABLE 32. OTSUKA PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 33. OTSUKA PHARMACEUTICAL CO.: KEY STRATERGIES
TABLE 34. FUJIFILM HOLDINGS CORP.: KEY EXECUTIVES
TABLE 35. FUJIFILM HOLDINGS CORP.: COMPANY SNAPSHOT
TABLE 36. FUJIFILM HOLDINGS CORP.: OPERATING SEGMENTS
TABLE 37. FUJIFILM HOLDINGS CORP.: PRODUCT PORTFOLIO
TABLE 38. FUJIFILM HOLDINGS CORP.: KEY STRATERGIES
TABLE 39. ETHICON, INC.: KEY EXECUTIVES
TABLE 40. ETHICON, INC.: COMPANY SNAPSHOT
TABLE 41. ETHICON, INC.: OPERATING SEGMENTS
TABLE 42. ETHICON, INC.: PRODUCT PORTFOLIO
TABLE 43. ETHICON, INC.: KEY STRATERGIES
TABLE 44. NOVO NORDISK A/S: KEY EXECUTIVES
TABLE 45. NOVO NORDISK A/S: COMPANY SNAPSHOT
TABLE 46. NOVO NORDISK A/S: OPERATING SEGMENTS
TABLE 47. NOVO NORDISK A/S: PRODUCT PORTFOLIO
TABLE 48. NOVO NORDISK A/S: KEY STRATERGIES
TABLE 49. OLYMPUS CORPORATION: KEY EXECUTIVES
TABLE 50. OLYMPUS CORPORATION: COMPANY SNAPSHOT
TABLE 51. OLYMPUS CORPORATION: OPERATING SEGMENTS
TABLE 52. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
TABLE 53. OLYMPUS CORPORATION: KEY STRATERGIES